By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Anavex Life Sciences Corp. 

51 West 52nd Street
7th floor
New York  New York  10019  U.S.A.
Phone: 1-844-689-3939 Fax: n/a


Company News
Biogen (BIIB) Forges Deal to Test Anavex (AVXL)'s Lead Drug Candidate 9/28/2016 6:07:25 AM
Anavex (AVXL)'s Puzzling Business Problems 8/15/2016 8:15:41 AM
Anavex (AVXL) Plummeted on Phase IIa Alzheimer's Results "Considered" Positive 7/28/2016 6:54:37 AM
Anavex (AVXL) Announces Positive Preclinical Data For ANAVEX 2-73 In Infantile Spasms 5/18/2016 2:08:00 PM
Anavex (AVXL)’s Alzheimer’s Drug a Possible Game Changer After Patients Reported Remarkable Positive Response 4/27/2016 6:33:14 AM
Anavex (AVXL) Release: U.S. FDA Grants Orphan Drug Designation To ANAVEX 3-71 For The Treatment Of Frontotemporal Dementia 4/8/2016 11:13:42 AM
Anavex (AVXL) Presents Preclinical Results Of ANAVEX 2-73 In Rett Syndrome 2/25/2016 10:21:57 AM
Anavex (AVXL) Release: ANAVEX 2-73 Preclinical Data In New Indication To Be Presented At ACTRIMS 2016. 2/17/2016 2:08:44 PM
Anavex (AVXL) Reports Fiscal First Quarter 2016 Financial Results 2/8/2016 10:15:05 AM
Anavex (AVXL) To Present At 18th Annual BIO CEO & Investor Conference On February 9th 2016 2/2/2016 9:45:53 AM